Scolaris Content Display Scolaris Content Display

Contenido relacionado

Ir a:

Revisiones y protocolos relacionados

Topics

Temas

Methodological quality graph for Christiaens 1990.
Figuras y tablas -
Figure 1

Methodological quality graph for Christiaens 1990.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Methodological quality summary: review authors' judgements about each methodological quality item for Christiaens 1990.
Figuras y tablas -
Figure 2

Methodological quality summary: review authors' judgements about each methodological quality item for Christiaens 1990.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 1 Betamethasone versus no treatment, Outcome 1 Neonatal thrombocytopenia.
Figuras y tablas -
Analysis 1.1

Comparison 1 Betamethasone versus no treatment, Outcome 1 Neonatal thrombocytopenia.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 1 Betamethasone versus no treatment, Outcome 2 Neonatal bleeding.
Figuras y tablas -
Analysis 1.2

Comparison 1 Betamethasone versus no treatment, Outcome 2 Neonatal bleeding.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 2 Betamethasone versus no treatment (worse‐case scenario)., Outcome 1 Overall neonatal thrombocytopenia.
Figuras y tablas -
Analysis 2.1

Comparison 2 Betamethasone versus no treatment (worse‐case scenario)., Outcome 1 Overall neonatal thrombocytopenia.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 2 Betamethasone versus no treatment (worse‐case scenario)., Outcome 2 Neonatal Bleeding.
Figuras y tablas -
Analysis 2.2

Comparison 2 Betamethasone versus no treatment (worse‐case scenario)., Outcome 2 Neonatal Bleeding.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 3 Betamethasone versus no medication (Best‐case scenario), Outcome 1 Neonatal bleeding.
Figuras y tablas -
Analysis 3.1

Comparison 3 Betamethasone versus no medication (Best‐case scenario), Outcome 1 Neonatal bleeding.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 4 Betamethasone versus no treatment (Intention‐to treat analysis)., Outcome 1 Neonatal thrombocytopenia.
Figuras y tablas -
Analysis 4.1

Comparison 4 Betamethasone versus no treatment (Intention‐to treat analysis)., Outcome 1 Neonatal thrombocytopenia.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 4 Betamethasone versus no treatment (Intention‐to treat analysis)., Outcome 2 Neonatal bleeding.
Figuras y tablas -
Analysis 4.2

Comparison 4 Betamethasone versus no treatment (Intention‐to treat analysis)., Outcome 2 Neonatal bleeding.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 5 Bethamethasone versus no treatment (best‐case scenario), Outcome 1 Overall neonatal thrombocytopenia.
Figuras y tablas -
Analysis 5.1

Comparison 5 Bethamethasone versus no treatment (best‐case scenario), Outcome 1 Overall neonatal thrombocytopenia.

Ir a la figura de la revisiónAbrir en una pestaña nueva
Comparison 1. Betamethasone versus no treatment

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Neonatal thrombocytopenia Show forest plot

1

Risk Ratio (IV, Fixed, 95% CI)

Subtotals only

1.1 Overall

1

28

Risk Ratio (IV, Fixed, 95% CI)

1.13 [0.62, 2.05]

1.2 Severe

1

28

Risk Ratio (IV, Fixed, 95% CI)

1.0 [0.16, 6.14]

1.3 Mild

1

28

Risk Ratio (IV, Fixed, 95% CI)

1.17 [0.52, 2.60]

2 Neonatal bleeding Show forest plot

1

28

Risk Ratio (IV, Fixed, 95% CI)

1.0 [0.24, 4.13]
Figuras y tablas -
Comparison 1. Betamethasone versus no treatment
Ir a la tabla de la revisión
Comparison 2. Betamethasone versus no treatment (worse‐case scenario).

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Overall neonatal thrombocytopenia Show forest plot

1

41

Risk Ratio (IV, Fixed, 95% CI)

1.97 [1.08, 3.59]

2 Neonatal Bleeding Show forest plot

1

41

Risk Ratio (IV, Fixed, 95% CI)

3.15 [0.99, 9.99]
Figuras y tablas -
Comparison 2. Betamethasone versus no treatment (worse‐case scenario).
Ir a la tabla de la revisión
Comparison 3. Betamethasone versus no medication (Best‐case scenario)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Neonatal bleeding Show forest plot

1

41

Risk Ratio (IV, Fixed, 95% CI)

0.32 [0.10, 0.98]
Figuras y tablas -
Comparison 3. Betamethasone versus no medication (Best‐case scenario)
Ir a la tabla de la revisión
Comparison 4. Betamethasone versus no treatment (Intention‐to treat analysis).

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Neonatal thrombocytopenia Show forest plot

1

Risk Ratio (IV, Fixed, 95% CI)

Subtotals only

1.1 Overall

1

41

Risk Ratio (IV, Fixed, 95% CI)

1.18 [0.57, 2.45]

1.2 Severe

1

41

Risk Ratio (IV, Fixed, 95% CI)

1.05 [0.16, 6.76]

1.3 Mild

1

41

Risk Ratio (IV, Fixed, 95% CI)

1.23 [0.50, 3.02]

2 Neonatal bleeding Show forest plot

1

41

Risk Ratio (IV, Fixed, 95% CI)

1.05 [0.24, 4.61]
Figuras y tablas -
Comparison 4. Betamethasone versus no treatment (Intention‐to treat analysis).
Ir a la tabla de la revisión
Comparison 5. Bethamethasone versus no treatment (best‐case scenario)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Overall neonatal thrombocytopenia Show forest plot

1

41

Risk Ratio (IV, Fixed, 95% CI)

0.63 [0.36, 1.10]
Figuras y tablas -
Comparison 5. Bethamethasone versus no treatment (best‐case scenario)
Ir a la tabla de la revisión